Sophie Pouplin
Research Subjects
Sophie Pouplin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Chenailler
Department of Pharmacy, Rouen University Hospital, F-76000 Rouen, France
2 shared publications - Eric Barat
Department of Pharmacy, Rouen University Hospital, Rouen, France
2 shared publications - Rémi Varin
Department of Pharmacy, Rouen University Hospital, F-76000 Rouen, France
2 shared publications - André Gillibert
Department of Biostatistics, CHU Rouen, F-76000, Rouen, France
1 shared publication - Baptiste Gerard
Department of Rheumatology, Rouen University Hospital, F-76000 Rouen, France
1 shared publication - Johanna Raymond
Department of Pharmacy, Rouen University Hospital, F-76000 Rouen, France
1 shared publication
Latest Publications
- Open Access
- 3 June 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (11) , 1138
An Overview of Opioid Prescription Patterns among Non-Opioid Users Following Emergency Department Admission
The evolving landscape of opioid prescription practices necessitates a comprehensive understanding of emerging patterns, particularly among new opioid users discharged from emergency departments. This study delves into the intricate realm of opioid utilization by elucidating the prevalence of their prescriptions. A retrospective analysis of electronic health records was conducted, including a cohort of 71 patients who received opioid prescriptions upon discharge from emergency departments from 1 January 2022 to 30 June 2022. Demographic characteristics and prescription details were systematically examined. This study illuminates tramadol’s prominence, with 84% of prescriptions and a Defined Daily Dose (DDD) morphine equivalent of 60 mg, as the primary choice as a new opioid, a finding that draws attention due to the closely aligned dosages with morphine equivalents. This discovery prompts a critical reassessment of tramadol’s therapeutic role, considering its multifaceted nature encompassing serotonergic effects and heightened fall risks. This study advocates for a nuanced and vigilant approach to tramadol prescription, cognizant of its potential risks and therapeutic implications, and highlights the imperative of optimizing data quality and traceability within electronic health records to enhance patient care and facilitate future research endeavors.
- 3 June 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (11) , 1138
Open AccessAn Overview of Opioid Prescription Patterns among Non-Opioid Users Following Emergency Department Admission
The evolving landscape of opioid prescription practices necessitates a comprehensive understanding of emerging patterns, particularly among new opioid users discharged from emergency departments. This study delves into the intricate realm of opioid utilization by elucidating the prevalence of their prescriptions. A retrospective analysis of electronic health records was conducted, including a cohort of 71 patients who received opioid prescriptions upon discharge from emergency departments from 1 January 2022 to 30 June 2022. Demographic characteristics and prescription details were systematically examined. This study illuminates tramadol’s prominence, with 84% of prescriptions and a Defined Daily Dose (DDD) morphine equivalent of 60 mg, as the primary choice as a new opioid, a finding that draws attention due to the closely aligned dosages with morphine equivalents. This discovery prompts a critical reassessment of tramadol’s therapeutic role, considering its multifaceted nature encompassing serotonergic effects and heightened fall risks. This study advocates for a nuanced and vigilant approach to tramadol prescription, cognizant of its potential risks and therapeutic implications, and highlights the imperative of optimizing data quality and traceability within electronic health records to enhance patient care and facilitate future research endeavors.
- Open Access
- 23 February 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (5) , 3967
Impact of Clinical Pharmacist Consultations on Postoperative Pain in Ambulatory Surgery
Post-operative pain is a common symptom of ambulatory surgery. The objective of this study was to evaluate a pain management protocol integrating a pharmacist consultation. We conducted a quasi-experimental, single center, before-after study. The control group was recruited between 1 March and 31 May 2018 and the intervention group between 1 March and 31 May 2019. Outpatients in the intervention group received a pharmacist consultation, in addition to the usual anesthesiologist and nurse consultations. Pharmacist consultations were conducted in two steps: the first step consisted of general open-ended questions and the second step of a specific and individualized pharmaceutical interview. A total of 125 outpatients were included in each group. There were 17% (95% CI 5 to 27%, p = 0.022) fewer patients with moderate to severe pain in the pharmaceutical intervention group compared with the control group, which corresponded to a decrease in the mean pain level of 0.9/10 (95% CI −1.5/10; −0.3/10; p = 0.002). The multivariate analysis did not reveal any confounding factors, showing that only the pharmaceutical intervention could explain this result. This study demonstrates a positive impact of pharmacist consultations on postoperative pain in ambulatory surgery.
- 23 February 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (5) , 3967
Open AccessImpact of Clinical Pharmacist Consultations on Postoperative Pain in Ambulatory Surgery
Post-operative pain is a common symptom of ambulatory surgery. The objective of this study was to evaluate a pain management protocol integrating a pharmacist consultation. We conducted a quasi-experimental, single center, before-after study. The control group was recruited between 1 March and 31 May 2018 and the intervention group between 1 March and 31 May 2019. Outpatients in the intervention group received a pharmacist consultation, in addition to the usual anesthesiologist and nurse consultations. Pharmacist consultations were conducted in two steps: the first step consisted of general open-ended questions and the second step of a specific and individualized pharmaceutical interview. A total of 125 outpatients were included in each group. There were 17% (95% CI 5 to 27%, p = 0.022) fewer patients with moderate to severe pain in the pharmaceutical intervention group compared with the control group, which corresponded to a decrease in the mean pain level of 0.9/10 (95% CI −1.5/10; −0.3/10; p = 0.002). The multivariate analysis did not reveal any confounding factors, showing that only the pharmaceutical intervention could explain this result. This study demonstrates a positive impact of pharmacist consultations on postoperative pain in ambulatory surgery.
- 11 March 2015
- Published by JLE in Douleur et Analgésie
- Vol. 28 (1) , 40-46
Éducation thérapeutique du patient (ETP) en rhumatologie : principales indications, modalités et évaluation
L’éducation thérapeutique du patient (ETP) place le patient comme un acteur de santé à part entière et a pour objectif l’amélioration de sa qualité de vie et son autonomisation. En rhumatologie, les rhumatismes inflammatoires chroniques (RIC), l’arthrose, les pathologies rachidiennes, l’ostéoporose et autres pathologies douloureuses chroniques sont des pathologies qui peuvent bénéficier de l’ETP. Nous décrivons dans cette revue ses principales indications, ses modalités pratiques de mise en oeuvre et son évaluation. The therapeutic patient education (TPE) considers patients as an important participant in their health management and aims to improve their quality of life and autonomy. In rheumatology, the inflammatory chronic arthritis, osteoarthritis, osteoporosis, chronic spine diseases and chronic pain diseases are good candidates for TPE procedures. In the present review, we describe TPE indications, practical usage and its scientific assessment.
- 11 March 2015
- Published by JLE in Douleur et Analgésie
- Vol. 28 (1) , 40-46
Éducation thérapeutique du patient (ETP) en rhumatologie : principales indications, modalités et évaluation
L’éducation thérapeutique du patient (ETP) place le patient comme un acteur de santé à part entière et a pour objectif l’amélioration de sa qualité de vie et son autonomisation. En rhumatologie, les rhumatismes inflammatoires chroniques (RIC), l’arthrose, les pathologies rachidiennes, l’ostéoporose et autres pathologies douloureuses chroniques sont des pathologies qui peuvent bénéficier de l’ETP. Nous décrivons dans cette revue ses principales indications, ses modalités pratiques de mise en oeuvre et son évaluation. The therapeutic patient education (TPE) considers patients as an important participant in their health management and aims to improve their quality of life and autonomy. In rheumatology, the inflammatory chronic arthritis, osteoarthritis, osteoporosis, chronic spine diseases and chronic pain diseases are good candidates for TPE procedures. In the present review, we describe TPE indications, practical usage and its scientific assessment.